SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001358403-19-000106
Filing Date
2019-08-05
Accepted
2019-08-05 16:13:13
Documents
70
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a2019q210q.htm 10-Q 1217158
2 EXHIBIT 31.1 exh3112019q2.htm EX-31.1 14289
3 EXHIBIT 31.2 exh3122019q2.htm EX-31.2 14551
4 EXHIBIT 32.1 exh3212019q2.htm EX-32.1 12619
  Complete submission text file 0001358403-19-000106.txt   5489633

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT blcm-20190630.xml EX-101.INS 1043751
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT blcm-20190630.xsd EX-101.SCH 37322
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT blcm-20190630_cal.xml EX-101.CAL 84555
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT blcm-20190630_def.xml EX-101.DEF 174512
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT blcm-20190630_lab.xml EX-101.LAB 554929
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT blcm-20190630_pre.xml EX-101.PRE 326985
Mailing Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030
Business Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36783 | Film No.: 19998773
SIC: 2834 Pharmaceutical Preparations